ReleaseWire Connect

Peripheral vascular disease (PVD) is narrowing of arteries outside brain and heart. Risk factors for the growth of PVD include hypertension, obesity, diabetes and smoking. More than 5% of the population above age 50 years suffers from PVD. Peripheral vascular devices are used for the treatment of these blocked arteries and remove the buildup plaque. Factors such as rapidly growing geriatric population, increasing incidences of peripheral vascular devices, rising minimally invasive surgeries support the growth of peripheral vascular devices market globally. For instance, it has been estimated that globally around 20% of the total population above the age of 65 years are affected by peripheral vascular diseases. In addition, changing lifestyle and increasing healthcare awareness, surge in high risk factors such as smoking and diabetes contributes towards increase in incidence rate of peripheral vascular diseases which would stimulate the growth of peripheral vascular devices market globally.

Nephrology and urology are the branches of medical science that deal with the study of kidney and urinary system, diseases and complications associated with it, their diagnosis (using variety of equipment) and types of treatment used to treat these complications. Nephrology, in particular, deals with kidney and urology deals with entire urinary system. The U.S. National Institute of Diabetes and Digestive and Kidney Diseases reported that more than 2 million kidney stone patients are diagnosed every year across the U.S. This high prevalence of kidney and urinary system diseases is likely to support the growth of this market during the forecast period from 2012 to 2018.

Diabetes, growing at an exponential rate worldwide, has become a serious health concern. The disease has emerged as a major cause of death of people between 20 years and 80 years of age. According to the American Diabetes Association, around 5% of the U.S. population has type 1 diabetes (approximately 1 million) and 95% of the population suffers from type 2 diabetes. Insulin plays an integral role in absorption of glucose from blood in case of type 1 and type 2 diabetes. Eli Lilly was the first company who made the human insulin commercially available in early 1980s. Since then insulin industry has been witnessing continuous advancements and innovations with various insulin derivatives available in the market. This report on insulin market analyzes the current as well as future prospects of the global and China market for insulin. This research is designed to estimate and analyze the demand and performance of insulin in the global market and also with special focus on the insulin market in China. This report on insulin provides in-depth analysis of the insulin market by revenue, volume, price trends and trend analysis by segments and demand in the global and China market.

Most pharmaceutical and medical devices companies are gradually outsourcing manufacturing activities to contract manufacturers in order to achieve efficiencies in cost, quality, capacity and time to market or to obtain specific expertise in particular business category, which is not available in-house. Moreover, increasing cost pressures, cost benefits and inclination of pharmaceutical companies to focus on core competencies such as R&D and marketing has created a need for outsourcing. Consequently, pharmaceutical and medical device companies are inclined toward outsourcing to concentrate on R&D and marketing of their products by minimizing the time invested in manufacturing practices. The market for contract manufacturing shows tremendous potential due to growth in the medical device industry, growing regulatory concerns and increasing demand from emerging countries.

According to the World Health Organization (WHO), unsafe injection practices cause more than 1.3 million deaths worldwide every year. The global healthcare industry has witnessed a surge in needlestick injuries, which has spurred the demand for retractable safety syringes worldwide. Needlestick injuries are mostly caused by sharing, reuse, or unsafe disposal of non-sterile syringes.

Global ECG Systems Market

This report analyzes and forecasts the market for tert-butanol at the global and regional level. The market has been forecast based on volume (kilo tons) and revenue (US$ Mn) from 2016 to 2024. The study includes drivers and restraints of the global tert-butanol market. It also covers the impact of these drivers and restraints on demand for tert-butanol during the forecast period. The report also highlights the opportunities in the tert-butanol market at the global and regional level.

The research study is designed to analyze the global hybrid power systems market. The market is calculated in terms of revenue (US$ Mn) based on the annual sales of hybrid power systems. The market for hybrid power systems has been segmented on the basis of type, end-use, and country/region. The global hybrid power systems market, based on type, has been segmented into wind-solar-diesel-hybrid, PV-diesel-hybrid, and others. On the basis of end-use, the hybrid power systems market has been segmented into residential, rural facility electrification, and others.

The report covers forecast and analysis for the global corn starch market on the global as well as regional levels. The study provides historical data of 2014 along with forecast for 2017 to 2024 based on volumes ('000 units) and revenue (US$ Mn). The study includes drivers, restraints, opportunities, and trends for the global corn starch market with their impact on demand during the forecast period. Market dynamics in the report are justified with the help of quantitative and qualitative data, which are verified by primary and secondary sources. The report includes segmentation, targeting & positioning (STP) analysis and value proposition analysis to enable clients to differentiate their strategy.

Plasma derived proteins are biological medicines used extensively in the treatment of rare, life-threatening, chronic, and genetic diseases. This report on the global plasma protein therapeutics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, which includes a market snapshot providing overall information on various segments and sub-segments. This section also provides complete information and data analysis of the global plasma protein therapeutics market with respect to the leading market segments based on product type, application, and geography. The report is a robust combination of primary and secondary research. Primary research formed the bulk of our research efforts with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various national and international databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro-environmental factors. Growth rates for each segment within the global plasma protein therapeutics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.